Patents-Review.com
ClassID:

97303 ⎘

C07K2317/80 - CPC Classification

Classification description:

Immunoglobulins specific features remaining in the (producing) cell, i.e. intracellular antibodies or intrabodies

Sub-classes:
Recent Application in this class:
#1
20260042852
2026-02-12

SINGLE-CHAIN DUPILUMAB ANTIBODY-TRANSFERRIN FUSION PROTEIN FOR ENHANCED EFFICACY AND INDICATIONS

 #2
20250296990
2025-09-25

ANTIBODIES AND THERAPEUTIC USES THEREOF

 #3
20250258180
2025-08-14

PEPTIDE TAG AND NUCLEIC ACID ENCODING SAME

 #4
20250171540
2025-05-29

PROTEIN-BASED T-CELL RECEPTOR KNOCKDOWN

 #5
20250129167
2025-04-24

DUAL SPECIFICITY ANTIBODIES TO PD-L1 AND PD-L2 AND METHODS OF USE THEREFOR

 #6
20250092131
2025-03-20

Anti-TREM1 Antibodies and Methods of Use Thereof

 #7
20250009845
2025-01-09

EXOSOMES FOR TARGET SPECIFIC DELIVERY AND METHODS FOR PREPARING AND DELIVERING THE SAME

 #8
20240343785
2024-10-17

INTRACELLULAR ANTIBODY AND PREPARATION METHOD AND USE THEREOF

 #9
20240207360
2024-06-27

Exosomes for target specific delivery and methods for preparing and delivering the same

 #10
20240075100
2024-03-07

Compositions Containing Protein Loaded Exosome and Methods for Preparing and Delivering the Same

 #11
20230121869
2023-04-20

Anti-TREM1 antibodies and methods of use thereof

 #12
20220396637
2022-12-15

SINGLE DOMAIN ANTIBODIES DIRECTED AGAINST INTRACELLULAR ANTIGENS

 #13
20220213221
2022-07-07

ANTI-RHO GTPASE CONFORMATIONAL SINGLE DOMAIN ANTIBODIES AND USES THEREOF

 #14
20220064269
2022-03-03

SINGLE CHAIN INTRABODIES THAT ALTER HUNTINGTIN MUTANT DEGRADATION

 #15
20220025025
2022-01-27

Antibodies and therapeutic uses thereof

 #16
20210347855
2021-11-11

Synthetic single domain antibody

 #17
20210308242
2021-10-07

Fusion proteins comprising an anti-CD40 antibody and cancer antigens

 #18
20210214445
2021-07-15

Dual specificity antibodies to PD-L1 and PD-L2 and methods of use therefor

 #19
20210171658
2021-06-10

Anti-rho GTPase conformational single domain antibodies and uses thereof

 #20
20210032334
2021-02-04

METHODS FOR TREATING CANCER USING COMBINATIONS OF ANTI-BTNL2 AND IMMUNE CHECKPOINT BLOCKADE AGENTS

 #21
20210024641
2021-01-28

Nucleic acids encoding anti-CD40 antibodies

 #22
20200317782
2020-10-08

Protein-based T-cell receptor knockdown

 #23
20200289614
2020-09-17

Compositions containing protein loaded exosome and methods for preparing and delivering the same

 #24
20200131264
2020-04-30

Anti-TREM1 antibodies and methods of use thereof

 #25
20200096507
2020-03-26

CHIMERIC RECEPTOR FOR USE IN WHOLE-CELL SENSORS FOR DETECTING ANALYTES OF INTEREST

 #26
20190381104
2019-12-19

MODIFIED HEMATOPOIETIC STEM/PROGENITOR AND NON-T EFFECTOR CELLS, AND USES THEREOF

 #27
20190177437
2019-06-13

Single domain antibodies directed against intracellular antigens

 #28
20190119361
2019-04-25

Immunoglobulin frameworks which demonstrate enhanced stability in the intracellular environment and methods of identifying same

 #29
20190085088
2019-03-21

Anti-CD40 antibodies

 #30
20180372750
2018-12-27

ANTIBODY AND ANTIBODY MIMETIC FOR VISUALIZATION AND ABLATION OF ENDOGENOUS PROTEINS

 #31
20180346876
2018-12-06

Chimeric antigen receptor cell preparation and uses thereof

 #32
20180327481
2018-11-15

Synthetic single domain antibody

 #33
20180319874
2018-11-08

Single chain intrabodies that alter Huntingtin mutant degradation

 #34
20180161369
2018-06-14

COMPOSITIONS FOR CELLULAR IMMUNOTHERAPY

 #35
20180117117
2018-05-03

Compositions containing protein loaded exosome and methods for preparing and delivering the same

 #36
20180094071
2018-04-05

Fusion proteins comprising an anti-CD40 antibody and HIV antigenic peptides

 #37
20180086831
2018-03-29

Protein-based T-cell receptor knockdown

 #38
20180072815
2018-03-15

Single Domain Antibodies Directed Against Intracellular Antigens

 #39
20180030117
2018-02-01

Synthetic single domain antibody

 #40
20180022794
2018-01-25

Anti-Rho GTPase conformational single domain antibodies and uses thereof

 #41
20170327598
2017-11-16

Single domain antibodies directed against intracellular antigens

 #42
20170320934
2017-11-09

Stabilized and autonomous antibody VH domain

 #43
20170210788
2017-07-27

MODIFIED POLYNUCLEOTIDES FOR THE PRODUCTION OF INTRABODIES

 #44
20170114142
2017-04-27

Method of making an anti-CD40 antibody

 #45
20170107272
2017-04-20

Immunoglobulin frameworks which demonstrate enhanced stability in the intracellular environment and methods of identifying same

 #46
20170044241
2017-02-16

Single chain intrabodies that alter huntingtin mutant degradation

 #47
20160331686
2016-11-17

Compositions and Methods for Yeast Extracellular Vesicles as Delivery Systems

 #48
20160250258
2016-09-01

MODIFIED HEMATOPOIETIC STEM/PROGENITOR AND NON-T EFFECTOR CELLS, AND USES THEREOF

 #49
20160237142
2016-08-18

Synthetic single domain antibody

 #50
20160208012
2016-07-21

Compositions and methods for treatment of cancer

 #51
20160194404
2016-07-07

Compositions and methods for treatment of cancer

 #52
20160159907
2016-06-09

Compositions and methods for treatment of cancer

 #53
20160130355
2016-05-12

Compositions and methods for treatment of cancer

 #54
20150346192
2015-12-03

Intracellular Phenotypic Screening

 #55
20150099299
2015-04-09

Compositions for treatment of cancer

 #56
20150093822
2015-04-02

Compositions for treatment of cancer

 #57
20140370017
2014-12-18

Methods for treatment of cancer

 #58
20140287426
2014-09-25

Antibody and antibody mimetic for visualization and ablation of endogenous proteins

 #59
20140234344
2014-08-21

Anti-CD40 antibodies

 #60
20140213640
2014-07-31

Virus-like particles for treatment of viral infections

 #61
20140155583
2014-06-05

Monoclonal antibodies and single chain antibody fragments against cell-surface prostate specific membrane antigen

 #62
20140106449
2014-04-17

Use of chimeric antigen receptor-modified T cells to treat cancer

 #63
20130287748
2013-10-31

Use of chimeric antigen receptor-modified T-cells to treat cancer

 #64
20130029366
2013-01-31

PTP1B inhibitors

 #65
20130028906
2013-01-31

Human antibodies that bind mesothelin, and uses thereof

 #66
20130028905
2013-01-31

Human antibodies that bind mesothelin, and uses thereof

 #67
20130028904
2013-01-31

Human antibodies that bind mesothelin, and uses thereof

 #68
20120231024
2012-09-13

Monoclonal antibodies and single chain antibody fragments against cell-surface prostate specific membrane antigen as diagnostic and therapeutic tools for prostate cancer

 #69
20120164673
2012-06-28

PTP1B INHIBITORS

 #70
20120114672
2012-05-10

Antibodies specific to cadherin-17

 #71
20120076804
2012-03-29

Cancer targeted innate immunity

 #72
20110262448
2011-10-27

Human antibodies that bind mesothelin, and uses thereof

 #73
20110184151
2011-07-28

SINGLE DOMAIN ANTIBODIES DIRECTED AGAINST EPIDERMAL GROWTH FACTOR RECEPTOR AND USES THEREFOR

 #74
20110123529
2011-05-26

SINGLE DOMAIN ANTIBODIES DIRECTED AGAINST EPIDERMAL GROWTH FACTOR RECEPTOR AND USES THEREFOR

 #75
20100297114
2010-11-25

Anti-CD40 targeted fusion proteins

 #76
20100291082
2010-11-18

Fusion protein with HIV antigen

 #77
20100291040
2010-11-18

Virus-like particles for treatment of viral infections

 #78
20100278814
2010-11-04

Prevention and treatment of synucleinopathic and amyloidogenic disease

 #79
20100239575
2010-09-23

Anti-CD40 antibodies

 #80
20100167957
2010-07-01

Methods for producing active scFv antibodies and libraries therefor

 #81
20100143371
2010-06-10

INTRABODIES

 #82
20100003253
2010-01-07

SINGLE DOMAIN ANTIBODIES DIRECTED AGAINST EPIDERMAL GROWTH FACTOR RECEPTOR AND USES THEREFOR

 #83
20090324579
2009-12-31

Anti-apoptotic protein antibodies

 #84
20090233358
2009-09-17

Method of Regulating A Phosphorylated Protein-Mediated Intracellular Signal Transduction Using An Antibody Specifically Binding To The Phosphorylated Protein

 #85
20090143247
2009-06-04

Methods for Producing Active scFv Antibodies and Libraries Therefor

 #86
20090041789
2009-02-12

Monoclonal antibodies and single chain antibody fragments against cell-surface prostate specific membrane antigen

 #87
20080233110
2008-09-25

Intrabodies with defined framework that is stable in a reducing environment and applications thereof

 #88
20070098741
2007-05-03

Vectors derived from antibodies for transferring substances into cells

 #89
20060257925
2006-11-16

Method for isolating intracellular antibodies able to neutralize protein interactions

 #90
20060233790
2006-10-19

Immunoglobulin/hydrophilic peptide complexes

 #91
20060228355
2006-10-12

Camelidae single domain antibodies vhh directed against epidermal growth factor receptor and uses therefor

 #92
20060150261
2006-07-06

Intracellular antibodies for a retrovirus protein

 #93
20060135459
2006-06-22

Targeted innate immunity

 #94
20060062793
2006-03-23

Modified antibodies to prostate-specific membrane antigen and uses thereof

 #95
20060035320
2006-02-16

Immunoglobulin frameworks which demonstrate enhanced stability in the intracellular environment and methods of identifying same

 #96
20060024301
2006-02-02

Prostate-specific polypeptides and fusion polypeptides thereof

 #97
20050282181
2005-12-22

Methods for identifying functional antibodies

 #98
20050108780
2005-05-19

Intracellular antibodies for a retrovirus protein